Literature DB >> 21450476

The importance of blood lactate clearance as a predictor of early mortality following the modified Norwood procedure.

Bari Murtuza1, Douglas Wall, Zdenka Reinhardt, John Stickley, Oliver Stumper, Timothy J Jones, David J Barron, William J Brawn.   

Abstract

OBJECTIVE: Optimisation of Norwood physiology, with focus on systemic perfusion, has beneficial effects on haemodynamic stability and perioperative mortality following the Norwood procedure for hypoplastic left heart syndrome. Early identification of high-risk patients during the postoperative phase might allow for institution of alternative management strategies with the possibility of avoiding poor outcome. Several studies have suggested that arterial blood lactate level, as an index of systemic perfusion and oxygen delivery, can to some extent predict mortality following paediatric cardiac surgery, though these studies have included heterogeneous groups of patients with only few Norwood patients. We sought to determine whether the blood lactate profile could be used to derive a simple, clinically applicable decision algorithm to direct therapy in a pre-emptive manner and perhaps identify patients for elective extracorporeal life support following the Norwood procedure.
METHODS: We retrospectively analysed all patients at our institution who had undergone modified Norwood procedures between March 2002 and May 2008. All patients had received right ventricle-pulmonary artery conduits. Patients with systemic-pulmonary shunts were excluded. Outcome measures included 7-day and 30-day mortality. Serial arterial blood lactate measurements were taken in all patients for at least 72h. Conditional inference tree modelling was used to determine the discriminatory value of the lactate profile and other pre- and intra-operative risk factors in terms of selecting survivors.
RESULTS: As many as 221 patients were included. The 7-day ICU mortality was 26/219 (11.8%) with total 30-day mortality of 35/219 (15.8%). There were 21 interstage deaths. Mortality modelling demonstrated that an inability to clear blood lactate levels to <6.76mmoll(-1) within the first 24h was highly discriminatory in terms of predicting death within the first 30 days. A total of 11 out of 12 patients in this group died. Other risk factors examined, including weight, ascending aorta size, cardiopulmonary bypass and ischaemic times, were not as predictive in our model.
CONCLUSION: We have identified minimum blood lactate level within the first 24h after the Sano-Norwood procedure as a highly discriminatory predictor of perioperative mortality. These patients might benefit from elective institution of early mechanical circulatory support.
Copyright © 2011 European Association for Cardio-Thoracic Surgery. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21450476     DOI: 10.1016/j.ejcts.2011.01.081

Source DB:  PubMed          Journal:  Eur J Cardiothorac Surg        ISSN: 1010-7940            Impact factor:   4.191


  11 in total

1.  Temporary restriction of right ventricle-pulmonary artery conduit flow using haemostatic clips following Norwood I reconstruction: potential for improved outcomes.

Authors:  Bari Murtuza; Timothy J Jones; David J Barron; William J Brawn
Journal:  Interact Cardiovasc Thorac Surg       Date:  2011-12-08

2.  Predictive value of lactate in unselected critically ill patients: an analysis using fractional polynomials.

Authors:  Zhongheng Zhang; Kun Chen; Hongying Ni; Haozhe Fan
Journal:  J Thorac Dis       Date:  2014-07       Impact factor: 2.895

3.  Prognostic Value of Blood Lactate and Lactate Clearance in Refractory Cardiac Arrest Treated by Extracorporeal Life Support.

Authors:  Romain Jouffroy; Anastasia Saade; Pascal Philippe; Pierre Carli; Benoit Vivien
Journal:  Turk J Anaesthesiol Reanim       Date:  2019-02-01

4.  Stage one Norwood procedure in an emerging economy:Initial experience in a single center.

Authors:  Rakhi Balachandran; Suresh G Nair; Sunil S Gopalraj; Balu Vaidyanathan; Brijesh P Kottayil; Raman Krishna Kumar
Journal:  Ann Pediatr Cardiol       Date:  2013-01

5.  Intraoperative change of lactate level is associated with postoperative outcomes in pediatric cardiac surgery patients: retrospective observational study.

Authors:  Tomoyuki Kanazawa; Moritoki Egi; Kazuyoshi Shimizu; Yuichiro Toda; Tatsuo Iwasaki; Hiroshi Morimatsu
Journal:  BMC Anesthesiol       Date:  2015-03-08       Impact factor: 2.217

6.  Effect of acid-base balance on postoperative course in children with hypoplastic left heart syndrome after the modified Norwood procedure.

Authors:  Marcin Gładki; Tomasz Składzień; Rafał Żurek; Elżbieta Broniatowska; Elżbieta Wójcik; Janusz H Skalski
Journal:  Medicine (Baltimore)       Date:  2017-08       Impact factor: 1.889

7.  Postoperative Serum Lactate Levels for In-Hospital Mortality Prediction Among Heart Transplant Recipients.

Authors:  Anna Kędziora; Karol Wierzbicki; Jacek Piątek; Hubert Hymczak; Izabela Górkiewicz-Kot; Irena Milaniak; Paulina Tomsia; Dorota Sobczyk; Rafał Drwiła; Bogusław Kapelak
Journal:  Ann Transplant       Date:  2020-05-26       Impact factor: 1.530

Review 8.  State of the Art of Machine Learning-Enabled Clinical Decision Support in Intensive Care Units: Literature Review.

Authors:  Na Hong; Chun Liu; Jianwei Gao; Lin Han; Fengxiang Chang; Mengchun Gong; Longxiang Su
Journal:  JMIR Med Inform       Date:  2022-03-03

9.  Serum arterial lactate concentration predicts mortality and organ dysfunction following liver resection.

Authors:  Matthew G Wiggans; Tim Starkie; Golnaz Shahtahmassebi; Tom Woolley; David Birt; Paul Erasmus; Ian Anderson; Matthew J Bowles; Somaiah Aroori; David A Stell
Journal:  Perioper Med (Lond)       Date:  2013-10-07

10.  Development of the Post Cardiac Surgery (POCAS) prognostic score.

Authors:  Eduardo Tamayo; Inma Fierro; Juan Bustamante-Munguira; María Heredia-Rodríguez; Pablo Jorge-Monjas; Laura Maroto; Esther Gómez-Sánchez; Francisco Bermejo-Martín; Francisco Alvarez; José Gómez-Herreras
Journal:  Crit Care       Date:  2013-09-24       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.